Bank Vontobel AG Share Price

Certificat

RMA4IV

CH1255344496

Market Closed - Swiss Exchange 16:20:00 10/10/2023 BST
96.5 CHF +0.10% Intraday chart for Bank Vontobel AG
1 month-3.31%
3 months-3.88%

Static data

Product typeAktienanleihen
Buy / SellCALL
Underlying ROCHE HOLDING AG
IssuerLogo Issuer Vontobel Vontobel
RMA4IV
ISINCH1255344496
Date issued 14/04/2023
Strike 277 CHF
Maturity 14/10/2024 (101 Days)
Parity 0.28 : 1
Emission price 100 CHF
Emission volume N/A
Settlement Beides
Currency CHF

Technical Indicators

Highest since issue 102.1 CHF
Lowest since issue 95 CHF

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
243.4 CHF
Average target price
276.4 CHF
Spread / Average Target
+13.57%
Consensus
  1. Stock Market
  2. Certificates
  3. RMA4IV Certificat